Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 562

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 562
---
          1 |   |

The accompanying notes are an integral part of these unaudited condensed financial statements.

| F-40 |

longevity biomedical, inc.

condensed Statements of changes in SHAREHOLDER’s DEFICIT (UNAUDITED)

| Balance at January 1, 2023           
 Issuance of common stock             
 Substantial premium on modified debt 
 Net loss                             |     | Shares | - 
 1 
 - 
 - |     | Amount | - 
 - 
 - |     | Paid-in 
 Capital |         - 
         - 
 6,201,403 
         - |     | Additional  
 Accumulated 
 Deficit     | (2,438,123  
 -           
 (7,001,036  | ) 
 ) |     | Shareholders’ 
 Deficit       | (2,438,123 
 -          
 6,201,403  
 (7,001,036 | ) 
 ) |
|:-------------------------------------|:----|:-------|--:|:----|:-------|:--|:----|:--------|----------:|:----|:------------|:------------|:--|:----|:--------------|:-----------|:--|
| Balance at March 31, 2023            |     |        | 1 |     | $      | - |     | $       | 6,201,403 |     | $           | (9,439,159  | ) |     | $             | (3,237,756 | ) |
| Net loss                             |     |        | - |     |        | - |     |         |         - |     |             | (708,472    | ) |     |               | (708,472   | ) |
| Balance at June 30, 2023             |     |        | 1 |     | $      | - |     | $       | 6,201,403 |     | $           | (10,147,631 | ) |     | $             | (3,946,228 | ) |
| Net loss                             |     |        | - |     |        | - |     |         |         - |     |             | (654,618    | ) |     |               | (654,618   | ) |
| Balance at September 30, 2023        |     |        | 1 |     | $      | - |     | $       | 6,